Article info
PDFShort report
Stromal MED12 exon 2 mutations in complex fibroadenomas of the breast
- Correspondence to Dr Hong Zhang, Department of Pathology, Memorial Sloan Kettering Cancer Center, New York 10065, New York, USA; zhangh3{at}mskcc.org
Citation
Stromal MED12 exon 2 mutations in complex fibroadenomas of the breast
Publication history
- Received August 26, 2020
- Revised November 23, 2020
- Accepted December 7, 2020
- First published December 29, 2020.
Online issue publication
January 19, 2022
Article Versions
- Previous version (19 January 2022).
- You are viewing the most recent version of this article.
Supplementary Data
This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.